Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C9Mab-11) by N-Terminal Peptide Immunization.
Tanaka T, Suzuki H, Isoda Y, Asano T, Nakamura T, Yanaka M, Handa S, Takahashi N, Okuno S, Yoshikawa T, Li G, Nanamiya R, Goto N, Tateyama N, Okada Y, Kobayashi H, Kaneko MK, Kato Y.
Tanaka T, et al. Among authors: nakamura t.
Monoclon Antib Immunodiagn Immunother. 2022 Dec;41(6):303-310. doi: 10.1089/mab.2022.0027. Epub 2022 Nov 16.
Monoclon Antib Immunodiagn Immunother. 2022.
PMID: 36383113